Defective PI3K/Akt pathway in T2DM results in insulin resistance and the activation of the pro-inflammatory, pro-apoptotic inhibition of eNOS and glycogen production
The defective PI3K/Akt pathway in T2DM results in insulin resistance and the activation of the pro-inflammatory, pro-apoptotic inhibition of eNOS and glycogen production. Insulin resistance and hyperglycemia hyperactivate the glucocorticoids and catecholamines. Glucocorticoids and catecholamines further aggravate T2DM by inhibiting the PI3K/Akt pathway, as indicated by the dotted inhibitory lines, thus potentiating insulin resistance and hyperglycemia. Glucocorticoids decrease GTP cyclohydrolase 1, which is required for NO generation from eNOS; increase ET-1 adhesion molecules; and activate NF-kβ, thus resulting in hypertension, endothelial dysfunction, and inflammation. These increase the risk of MI. Catecholamines result in Ca2+ overload by increasing the phosphorylation of PLN, activating SERCA calcium release, and causing leakage of RyR2 and DHPR2 receptors. Ca2+ overload results in mitochondrial ROS, contractile dysfunction, and arrhythmias, and these are reported to cause MI. Catecholamines also stimulate the release of renin and the activation of RAAS. Hyperactivation of the RAAS causes hypertension and increases the risk of MI. The effect of insulin resistance and hyperglycemia on opioids is not apparent, but studies have reported that opioids are elevated in hyperglycemia. The green arrows indicate that opioids activate insulin’s PI3K/Akt pathway, GLUT4 receptor translocation to the membrane, and reduced blood glucose. Opioids also inhibit adenylyl cyclase and cAMP, thus inhibiting the PKA pathway and its downstream effects. Black ↓ indicates an activation or stimulation in the pathway. Red ↓ indicates a decrease. Red ↑ indicates a increase. A black solid ┴ indicates an inhibition. X indicates defects in the insulin signaling pathway in T2DM. Black dashed lines ending with ┴ show inhibition due to the HPA-axis pathway. Brown dashed lines ending with ┴ indicate inhibition due to opioid activation. Green arrows illustrate that opioids reduce blood glucose by activating the PI3K/Akt pathway
Publication
The Role of Pro-Opiomelanocortin Derivatives in the Development of Type 2 Diabetes-Associated Myocardial Infarction: Possible Links with Prediabetes (2024) Nompumelelo Anna-Cletta Gumede, et al. Biomedicines. 2024 Feb;12(2). Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | HPA- | HPA | ncbigene_synonym | HPSE | 10855 |
| Homo sapiens | Primates | OPS | OPS | ncbigene_synonym | LRP5 | 4041 |
| Homo sapiens | Primates | SNS | SNS | ncbigene_synonym | SCN10A | 6336 |
| Homo sapiens | Primates | GCR | GCR | ncbigene_synonym | NR3C1 | 2908 |
| Homo sapiens | Primates | IRS | IRS | ncbigene_synonym | IARS1 | 3376 |
| Homo sapiens | Primates | IRS | IRS | famplex_relations | IRS1 | 3667 |
| Homo sapiens | Primates | IRS | IRS | famplex_relations | IRS2 | 8660 |
| Homo sapiens | Primates | IRS | IRS | famplex_relations | IRS4 | 8471 |
| Homo sapiens | Primates | Akt | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | Akt | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | GTP | GTP | ncbigene_synonym | MTG1 | 92170 |
| Homo sapiens | Primates | GSK3 | GSK3 | famplex_relations | GSK3A | 2931 |
| Homo sapiens | Primates | GSK3 | GSK3 | famplex_relations | GSK3B | 2932 |
| Homo sapiens | Primates | GLUT4 | GLUT4 | ncbigene_synonym | SLC2A4 | 6517 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY1 | 107 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY2 | 108 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY3 | 109 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY4 | 196883 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY5 | 111 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY6 | 112 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY7 | 113 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY8 | 114 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY9 | 115 |
| Homo sapiens | Primates | AC | ADCY | famplex_relations | ADCY10 | 55811 |
| Homo sapiens | Primates | eNOS | ENOS | ncbigene_synonym | NOS3 | 4846 |
| Homo sapiens | Primates | eNOS | ENOS | ncbigene_synonym | ENO4 | 387712 |
| Homo sapiens | Primates | GS | GS | famplex_relations | GNAS | 2778 |
| Homo sapiens | Primates | GS | GS | famplex_relations | GNAL | 2774 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | IKK | IKK | famplex_relations | CHUK | 1147 |
| Homo sapiens | Primates | IKK | IKK | famplex_relations | IKBKB | 3551 |
| Homo sapiens | Primates | IKK | IKK | famplex_relations | IKBKG | 8517 |
| Homo sapiens | Primates | IKK | IKK | famplex_relations | IKBKE | 9641 |
| Homo sapiens | Primates | IKK | IKK | famplex_relations | TBK1 | 29110 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP1 | 834 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP2 | 835 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP4 | 837 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP5 | 838 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP6 | 839 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP8 | 841 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP9 | 842 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP10 | 843 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP12 | 100506742 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP14 | 23581 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP3 | 836 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP7 | 840 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1A | 5573 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR1B | 5575 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2A | 5576 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKAR2B | 5577 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACA | 5566 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACB | 5567 |
| Homo sapiens | Primates | PKA | PKA | famplex_relations | PRKACG | 5568 |
| Homo sapiens | Primates | ET-1 | ET1 | ncbigene_synonym | EDN1 | 1906 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | PLN | PLN | ncbigene_symbol | PLN | 5350 |
| Homo sapiens | Primates | RYR2 | RYR2 | ncbigene_symbol | RYR2 | 6262 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A1 | 487 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A2 | 488 |
| Homo sapiens | Primates | SERCA | SERCA | famplex_relations | ATP2A3 | 489 |
| Homo sapiens | Primates | ATGL | ATGL | ncbigene_synonym | PNPLA2 | 57104 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| OPS | OPS | chebi:76674 | ||
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| GTP | GTP | GTP | chebi:37565 | |
| CAMP | cAMP | adenosine 3',5'-(hydrogen phosphate) | chebi:17489 | |
| molecules | molecules | chebi:25367 | ||
| Glycogen | Glycogen | chebi:28087 | ||
| pro- | Pro- | (2S)-pyrrolidine-2-carbonyl | chebi:32865 | |
| ATP | ATP | ATP | chebi:30616 | |
| SERCA | SerCA | L-serocholate | chebi:229711 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| hypertension | hypertension | hypertension | DOID:10763 | |
| hypertension | hypertension | hypertension | DOID:10763 |